Avacta Group Plc (LON:AVCT – Get Free Report)’s stock price shot up 13.9% on Thursday . The company traded as high as GBX 46 ($0.58) and last traded at GBX 45.55 ($0.58). 4,701,340 shares changed hands during trading, an increase of 92% from the average session volume of 2,447,282 shares. The stock had previously closed at GBX 40 ($0.51).
Avacta Group Price Performance
The company has a quick ratio of 4.96, a current ratio of 0.62 and a debt-to-equity ratio of 191.87. The company has a market capitalization of £170.54 million, a price-to-earnings ratio of -527.78 and a beta of 1.22. The business has a 50-day moving average price of GBX 44.03 and a two-hundred day moving average price of GBX 73.46.
Avacta Group Company Profile
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Featured Articles
- Five stocks we like better than Avacta Group
- What Are Dividend Challengers?
- McDonald’s Stock: Balancing Value and Innovation
- Find and Profitably Trade Stocks at 52-Week Lows
- MarketBeat Week in Review – 6/17 – 6/21
- Top Biotech Stocks: Exploring Innovation Opportunities
- Sarepta Therapeutics Stock Soars on FDA Approval
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
